3-98133000-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005338.2(OR5H1):āc.303T>Gā(p.Phe101Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000342 in 1,613,538 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005338.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5H1 | NM_001005338.2 | c.303T>G | p.Phe101Leu | missense_variant | 2/2 | ENST00000641874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5H1 | ENST00000641874.1 | c.303T>G | p.Phe101Leu | missense_variant | 2/2 | NM_001005338.2 | P1 | ||
ENST00000508964.1 | n.94+15041A>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152002Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000283 AC: 71AN: 250906Hom.: 0 AF XY: 0.000332 AC XY: 45AN XY: 135612
GnomAD4 exome AF: 0.000348 AC: 509AN: 1461418Hom.: 1 Cov.: 36 AF XY: 0.000355 AC XY: 258AN XY: 727028
GnomAD4 genome AF: 0.000283 AC: 43AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.303T>G (p.F101L) alteration is located in exon 1 (coding exon 1) of the OR5H1 gene. This alteration results from a T to G substitution at nucleotide position 303, causing the phenylalanine (F) at amino acid position 101 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at